Veteran health executives Elena Castañeda and Dr. Emily Maxson have launched Mangrove Health, a primary‑care network based in Miami. Castañeda takes the helm as CEO while Maxson serves as medical director. The firm entered the market with fresh capital from Mako Capital Group and Despierta, signaling a new entrant in a crowded outpatient sector.

The infusion will fund rapid expansion across Florida, where the duo plans to open several clinical centers in the next year. By aligning with major health‑plan sponsors, Mangrove aims to capture a share of the state’s growing demand for value‑based primary care. Investors see the partnership as a conduit to scale quickly.

Mako’s entry reflects a broader trend of private‑equity firms targeting primary‑care platforms that can integrate telehealth, data analytics and bundled‑payment models. Despierta, a Latino‑focused investor, adds strategic depth by tapping into diverse patient populations. Together, the backers provide not just funding but operational expertise to navigate regulatory hurdles and payer negotiations.

With capital secured, Mangrove Health can now convert its leadership vision into tangible clinics, potentially reshaping primary‑care delivery in the Sun Belt. Early market entry gives it a timing advantage over rivals still seeking funding, positioning the firm to negotiate favorable contracts with insurers before the sector becomes saturated.